NBW Capital LLC cut its position in shares of Danaher Co. (NYSE:DHR – Free Report) by 2.5% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 25,435 shares of the conglomerate’s stock after selling 658 shares during the period. NBW Capital LLC’s holdings in Danaher were worth $5,839,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also bought and sold shares of the company. Heck Capital Advisors LLC bought a new stake in Danaher during the 4th quarter valued at $27,000. Decker Retirement Planning Inc. bought a new stake in Danaher during the 4th quarter valued at $31,000. Golden State Wealth Management LLC bought a new stake in Danaher during the 4th quarter valued at $31,000. Strategic Financial Concepts LLC bought a new stake in Danaher during the 4th quarter valued at $31,000. Finally, Pineridge Advisors LLC raised its position in Danaher by 63.3% during the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after purchasing an additional 57 shares in the last quarter. 79.05% of the stock is owned by institutional investors.
Analyst Ratings Changes
Several research firms have recently commented on DHR. Guggenheim began coverage on Danaher in a research report on Thursday, December 19th. They issued a “buy” rating and a $275.00 price target for the company. Royal Bank of Canada reissued an “outperform” rating and issued a $277.00 price target (down from $299.00) on shares of Danaher in a research report on Thursday, January 30th. Robert W. Baird reduced their price target on Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Barclays reduced their price target on Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research report on Thursday, January 30th. Finally, Jefferies Financial Group reduced their price target on Danaher from $285.00 to $260.00 and set a “buy” rating for the company in a research report on Wednesday, January 29th. Seven analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $278.00.
Insider Buying and Selling at Danaher
In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the sale, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 11.10% of the stock is owned by corporate insiders.
Danaher Stock Down 1.0 %
Danaher stock opened at $205.60 on Tuesday. The firm has a market cap of $146.94 billion, a price-to-earnings ratio of 38.94, a price-to-earnings-growth ratio of 2.66 and a beta of 0.83. Danaher Co. has a 52 week low of $196.80 and a 52 week high of $281.70. The business’s 50-day moving average price is $224.11 and its 200 day moving average price is $244.31. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31.
Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period last year, the company earned $2.09 EPS. As a group, sell-side analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current year.
Danaher Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a $0.32 dividend. This is a positive change from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a yield of 0.62%. The ex-dividend date is Friday, March 28th. Danaher’s dividend payout ratio (DPR) is presently 24.24%.
Danaher Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More
- Five stocks we like better than Danaher
- How to Calculate Stock Profit
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- Top Biotech Stocks: Exploring Innovation Opportunities
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- Breakout Stocks: What They Are and How to Identify Them
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.